Hospitalization Rates Overestimate COVID-19 Burden in Children
Reported hospitalization rates overestimate the burden of COVID-19 in children.
Pediatric Endocrinology
Pediatric Thyroid Nodules: Malignancy Linked to Radiation Exposure
Researchers evaluated the utility of ultrasound characteristics for refining malignancy risk to inform the management of cytologically indeterminate pediatric thyroid nodules.
Medication Organizers Often Contain “One Pill Can Kill” Meds
While known to increase patient compliance, medication organizers, such as blister packs and pill boxes, have also been associated with unintentional pediatric medication exposures.
Moderna COVID-19 Vaccine Highly Effective in Children 12 and Older
The Moderna COVID-19 vaccine fully protects children aged 12 to 17 years.
Diabetes Educator, Nutritionist Facilitate Successful Transition From Pediatric to Adult Care for Type 1 Diabetes
Researchers from Duke University Health System reported findings from their study assessing care among adolescents and young adults with type 1 diabetes during their transition from pediatric to adult care.
High Adolescent BMI Increases Stroke Risk in Young Adults With, Without Diabetes
The association between stroke and obesity in adolescence was examined in a population-based study.
Dasiglucagon Rapidly Restores Plasma Glucose in Children With Insulin-Induced Hypoglycemia
The researchers’ objective was to evaluate the safety and efficacy of dasiglucagon in patients aged 6 to 17 years with type 1 diabetes.
Poll Finds Many Parents Hesitant to Get Younger Children Vaccinated
As US health officials prepare to authorize the Pfizer COVID-19 vaccine for emergency use in younger children, a new poll shows that less than a third of parents would get their child vaccinated as soon as the shots are approved.
Exposure to Ambient Air Pollutants May Up BP in Children, Teens
Among children and adolescents, short- and long-term exposure to some ambient air pollutants may increase blood pressure.
Canada Approves Pfizer COVID-19 Vaccine for Children Ages 12 to 15
The Pfizer COVID-19 vaccine has been approved by Canadian health officials for use in children ages 12 to 15 years.
- Loading...
Loading...
Next post in General Endocrinology
Loading... 
Loading...